PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 28, 2024Calcified Tissue International6 citationsOpen Access

Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank

View Full Paper
CFChristine L. FreerEGElena S. GeorgeSTSze‐Yen Tan

Key Points

Key points are not available for this paper at this time.

Abstract

Sarcopenia may increase non-alcoholic fatty liver disease (NAFLD) risk, but prevalence likely varies with different diagnostic criteria. This study examined the prevalence of sarcopenia and its defining components in adults with and without NAFLD and whether it varied by the method of muscle mass assessment bioelectrical impedance (BIA) versus dual-energy X-ray absorptiometry (DXA) and adjustment (height

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Freer et al. (2024) studied this question.

synapsesocial.com/papers/68e6d2ecb6db643587650deahttps://doi.org/10.1007/s00223-024-01212-5
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sarcopenia as a risk factor for nonalcoholic fatty liver disease and liver fibrosis: an updated systematic review and meta-analysis2026
  2. 2Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease2024 · 8 citations
  3. 3Nutritional Status and Sarcopenia in Patients with Non-Alcoholic Fatty Liver Disease at a Private Hospital in Coimbatore, India2025
  4. 4Sarcopenia index for detecting of the decreased muscle strength and mass in patients with the non-alcoholic fatty liver disease2025
  5. 5Ultrasound Assessment of Sarcopenia in Alcoholic Liver Disease2024 · 2 citations